GLP-1 TV · News & media
Wegovy Deal Makes Cofounder Of Hair Loss Pill Seller Hims, A Billionaire
Today’s cheapest Wegovy$208/mo at Sesame Care, an average: a $59/mo subscription billed $708 once a year, with medication billed monthly.Compare all Wegovy prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. Not from the video’s creator.Our summary
The report says the company's market cap was close to $12 billion at market close on Wednesday. It also says first quarter revenue rose 111% to $586 million, up from $278 million a year earlier, and net income rose to $49.5 million from 11.1 million.
Published by Forbes on YouTube
As published by the channel. Not medical advice, and not an endorsement.
What else the video covers
The report says the stock has risen 73% since the announcement. It adds that this reversed a sharp drop after a February Food and Drug Administration decision to stop telehealth companies from making compounded versions of the drug, which had been allowed during shortages of semaglutide. The channel estimates Dudum's net worth at $1.1 billion, nearly all of it in company stock and options.
The second half covers Dudum's background and the company's history. The video says he is 36, attended Wharton, and co-founded the startup studio Atomic Ventures in 2012. According to the report, the company spent nearly half of its $1.5 billion in revenue on marketing last year and lets customers get prescriptions through an online intake form and an online exam.
Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.
Takeaways
The main points, in the order they come up. Tap a time to play from there.
- 0:32 The video says first quarter revenue rose 111% to $586 million and net income reached $49.5 million.
- 1:32 The video explains that the stock had earlier fallen after a February FDA decision to stop telehealth firms from making compounded versions.
- 2:03 The channel estimates Dudum's net worth at $1.1 billion, mostly in company shares and options.
- 3:34 The report says the company spent nearly half of its $1.5 billion in revenue on marketing last year.
Key moments
Tap one to play from there.
What the video says
As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.
- Medication
- Wegovy
- Side effects mentioned
- hair loss
Videos on the same question
The closest videos in the library by what is said in them, not by title.
HIMS Growth Potential, Weight-loss Drug PipelineAccording to the video, the company reported earnings of 20 cents a share on 586 million dollars of revenue.- Already on Wegovy? What your next month costs at every programToday’s lowest is $208/mo. Every program ranked by price alone.
‼️HIMS CANCELS WEIGHT LOSS PILL! 💥 IS THIS THE END?!The creator says that on February 5th the company announced a personalized compounded semaglutide pill starting at $49 a month, described as having the same active ingredient as Wegovy.
Popular weight loss drug Wegovy drops cash price 30%, manufacturer saysThis segment reports that Novo Nordisk is lowering the self-pay price of Wegovy, according to the video.
HIMS Core Business Faces Challenges in Guidance, GLP-1 Prices & NVOThe host notes that shares fell at first and then turned positive on the day.
Read next
Our guides closest to what this video covers, with prices checked weekly.
- Is Hims legit? What its GLP-1 program costs, what reviews say, and its FDA record
Yes. Hims & Hers is a real, licensed telehealth company, and as of October 2026 its weight-loss program sells FDA-approved brand-name GLP-1s: the Wegovy pill starts at $149 a month for the medication, plus a membership of $39 for the first month and $149 a month after, so about $298 a month from month two. It scores 2.9 on Trustpilot across 9,517 reviews, and FDA sent it a warning letter in September 2025 over compounded semaglutide marketing claims.
- How much does Wegovy cost: the pen, the pill, insured, cash, Medicare and compounded, in one table
Wegovy costs six different amounts depending on who is paying. A commercial plan that covers it brings it to $25 a month with Novo's card, capped at $100 of savings. Medicare covers it for $50 a month through the GLP-1 Bridge until the end of 2027. Cash, the pen is $349 a month at every dose, $199 for the first two fills if you are new, and $399 for the 7.2 mg HD pen; the pill is $149, $199 or $299 by strength. Compounded semaglutide, which is not FDA-approved, starts at $39 on our board. This page holds all six with their conditions and their sources.
- The Wegovy pill: what it costs, how well it works and how it compares with the pen
The Wegovy pill is a once-a-day semaglutide tablet for weight loss, FDA-approved and on sale since January 2026. Paying cash, Novo Nordisk charges $149 a month at the starting dose, $199 at the second step and $299 at the higher doses, against $349 a month for the Wegovy pen. In its main trial, people on the full-strength tablet lost 13.6% of their body weight on average over 64 weeks.
Next steps
Wegovy prices
Find more like it
Cost and insuranceHair loss
Up next
More from this collection
Watched it? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.




















